<div class="docx-content">
<h1 class="text-2xl font-bold mt-8 mb-4">Bartonella <strong>1) Essentials at a Glance</strong></h1><ul><li><strong>Genus</strong>: <ul><li>small, fastidious, aerobic/microaerophilic Gram-negative bacilli; </li><li>facultative intracellular (endothelium ± erythrocytes). </li><li>Oxidase-, catalase-, urease-, nitrate- negative; </li><li>biochemically inert (diagnosis is <strong>serology/PCR</strong>, not phenotypic panels). </li></ul></li><li><strong>Key human pathogens &amp; reservoirs/vectors</strong><ul><li><em>B. henselae</em> <ul><li>cats (reservoir); <strong>cat fleas</strong> vector</li><li>cat-scratch disease (CSD), osteomyelitis, neuroretinitis/POGS, hepatosplenic disease; bacillary angiomatosis/peliosis in immunocompromise; IE (less common than <em>B. quintana</em>). </li></ul></li><li><em>B. quintana</em> <ul><li><strong>human reservoir</strong>; <strong>body lice</strong> vector </li><li>trench fever (relapsing fever, shin pain), chronic bacteremia in people experiencing homelessness, <strong>blood-culture–negative IE (BCNIE)</strong>. </li></ul></li><li><em>B. bacilliformis</em> <ul><li><strong>sandflies (Lutzomyia)</strong> in Andes </li><li>Carrion’s disease: <strong>Oroya fever</strong> (acute hemolytic anemia) then <strong>verruga peruana</strong> (angioproliferative lesions). </li></ul></li></ul></li><li><strong>Diagnostic Strategy (pragmatic, exam-style)</strong><ul><li>BCNIE</li><li>relapsing fever with lice exposure</li><li>unilateral tender nodes after cat exposure</li><li>HIV with angiomatous lesions</li><li>Peruvian/Andean travel with hemolysis </li><li>vascular nodules.</li></ul></li></ul><h1 class="text-2xl font-bold mt-8 mb-4"><strong>2) Laboratory Microbiology (bench &amp; reference)</strong></h1><ul><li><strong>Serology</strong></li><li><strong>PCR </strong>on tissue &gt; blood.</li><li><strong>Culture</strong>: extremely fastidious; slow growth on enriched blood/chocolate (5% CO₂), often <strong>weeks</strong>; isolation from blood is uncommon without enrichment cell culture (e.g., BAPGM/insect-cell media). </li><li><strong>Stains Histology</strong>: Warthin–Starry or Steiner silver stains highlight bacilli in BA/peliosis; lymph nodes may show stellate microabscesses; </li><li><strong>Immunohistochemistry m</strong>ore sensitive than silver for <em>B. henselae</em> in nodes. <a href="https://www.ncbi.nlm.nih.gov/books/NBK586304/bin/oppguide.pdf">NCBI</a><a href="https://pubmed.ncbi.nlm.nih.gov/31913159/?utm_source=chatgpt.com">PubMed</a></li><li><strong>Biochemical profile</strong>: oxidase-, catalase-, urease-, nitrate-negative; </li><li><strong>Safety</strong>: BSL-2 practices; alert the lab for suspected BCNIE/BA specimens.</li><li>Blood films: in Oroya fever</li></ul><h1 class="text-2xl font-bold mt-8 mb-4"><strong>4) Clinical Syndromes (with treatment)</strong></h1><h2 class="text-xl font-semibold mt-6 mb-3"><strong>A) Cat-Scratch Disease (CSD) — <em>B. henselae</em></strong></h2><ul><li><strong>Typical</strong>: <ul><li>papule at inoculation </li><li><strong>unilateral regional lymphadenitis</strong> (axillary/epitrochlear)</li><li>low-grade fever</li><li>often self-limited (2–8 w).</li></ul></li><li><strong>Atypical</strong>: <ul><li>hepatosplenic lesions</li><li>Osteomyelitis</li><li>Neuroretinitis/POGS</li><li>encephalopathy. </li></ul></li><li><strong>Antibiotics</strong>: <ul><li>not always required; <strong>azithromycin shortens lymph node volume</strong> (5-day course). </li><li>Dose: 500 mg day 1 then 250 mg daily days 2–5 (adults/children &gt;45.5 kg). </li></ul></li><li><strong>Suppuration</strong>: consider <strong>needle aspiration</strong> for pain relief</li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>B) Ocular Bartonella (neuroretinitis, Parinaud’s oculoglandular syndrome)</strong></h2><ul><li><strong>Treatment (common practice)</strong>: <ul><li><strong>doxycycline 100 mg bd + rifampicin 300 mg bd for 4–6 wks</strong></li><li>corticosteroids sometimes adjunctive in severe neuroretinitis (after antibiotics are started). </li></ul></li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>C) Bacillary angiomatosis / peliosis hepatis (usually HIV or profound immunosuppression)</strong></h2><ul><li><strong>Clinical</strong>: <ul><li>angiomatous skin lesions (may resemble Kaposi)</li><li>systemic symptoms</li><li>peliosis </li><li>hepatic/splenic vascular lesions ± hemorrhage.</li></ul></li><li><strong>Treat</strong>:<ul><li><strong>doxycycline 100 mg q12h OR erythromycin 500 mg q6h for  ≥3 months</strong> and until lesions resolve; add </li><li><strong>rifampicin</strong> or use CNS-penetrating agents if CNS eye disease.</li><li>Optimise ART. </li></ul></li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>D) Trench fever / chronic bacteremia — <em>B. quintana</em></strong></h2><ul><li><strong>Features</strong>: <ul><li>association with body lice and homelessness</li><li>relapsing fever</li><li>severe bone/shin pain</li><li>may progress to IE.</li></ul></li><li><strong>Treat (typical)</strong>: <ul><li><strong>doxycycline 100 mg bd for ≥4 wks</strong>; </li><li>in severe disease or IE suspicion add <strong>gentamicin</strong> for 14 days. </li></ul></li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>E) Infective endocarditis (BCNIE) — <em>B. quintana</em> &gt; <em>B. henselae</em></strong></h2><ul><li><strong>Clues</strong>: BCNIE, homelessness/lice or cat exposure; <strong>ANCA-positive pauci-immune GN</strong> can mimic vasculitis — avoid steroids until IE excluded. <a href="https://wwwnc.cdc.gov/eid/article/31/4/24-1812_article/?utm_source=chatgpt.com">CDC Travelers' Health</a></li><li><strong>Regimens (evidence-based options)</strong><ul><li><strong>Option 1</strong>: <strong>Doxycycline 100 mg q12h + rifampicin 300 mg q12h for 6 wks</strong>, then <strong>continue doxycycline for ≥3 mo</strong>. <a href="https://www.ncbi.nlm.nih.gov/books/NBK586304/bin/oppguide.pdf">NCBI</a></li><li><strong>Option 2</strong>: <strong>Doxycycline 100 mg q12h + gentamicin 1 mg/kg q8h for 2 wks</strong>, then <strong>continue doxycycline</strong> to complete at least <strong>6 wks</strong>. <a href="https://www.ncbi.nlm.nih.gov/books/NBK586304/bin/oppguide.pdf">NCBI</a></li><li>ESC 2023 emphasises systematic Bartonella serology in BCNIE work-ups; 2023 <strong>Duke-ISCVID</strong> recognises <strong>Bartonella IgG ≥1:800</strong> (or Bartonella PCR) as <strong>Major</strong>. Surgical management per standard IE indications. <a href="https://sochicar.cl/wp-content/uploads/2023/09/ehad193.pdf">sochicar.cl</a><a href="https://www.iscvid.org/wp-content/uploads/2023/07/2023-The-2023-Duke-ISCVID-Criteria-for-Infective-Endocarditis-Fowler-CID-May-4-2023-Final.pdf?utm_source=chatgpt.com">iscvid.org</a></li></ul></li></ul><h2 class="text-xl font-semibold mt-6 mb-3"><strong>F) Carrion’s disease — <em>B. bacilliformis</em> (travel history to Andes)</strong></h2><ul><li><strong>Oroya fever (acute hemolytic phase)</strong>: <ul><li>Hospitalise</li><li><strong>ciprofloxacin</strong> or <strong>ceftriaxone</strong> commonly used; </li><li>supportive transfusion as needed</li></ul></li><li><strong>Verruga peruana </strong><ul><li><strong>chronic angioproliferative phase</strong>: </li><li><strong>azithromycin 7–14 days</strong>, or <strong>rifampicin 21–28 days</strong>; fluoroquinolones are alternatives;</li></ul></li></ul><h1 class="text-2xl font-bold mt-8 mb-4"><strong>5) Antimicrobial Notes (what to know for viva)</strong></h1><ul><li><strong>Intracellular location</strong> → <strong>tetracyclines/macrolides</strong> preferred; <strong>aminoglycosides</strong> (gentamicin) provide <strong>early bactericidal</strong> activity in IE. <strong>Cephalosporins alone are not reliable</strong> for Bartonella disease (exception: ceftriaxone used in Oroya fever as alternative). </li><li><strong>Susceptibility testing</strong> is not standardised; results correlate poorly with outcomes. Use <strong>syndrome-based regimens</strong> and duration. </li></ul><h1 class="text-2xl font-bold mt-8 mb-4"><strong>6) Epidemiology &amp; Prevention (high-yield points)</strong></h1><ul><li><strong>Avoid fleas, body lice and sandflies .</strong></li></ul><h1 class="text-2xl font-bold mt-8 mb-4"><strong>7) Pitfalls &amp; Exam Pearls</strong></h1><ul><li><strong>BCNIE work-up</strong>: Always send <strong>Bartonella and Coxiella serology</strong> early; if surgery occurs, <strong>send valve for PCR</strong> (highest diagnostic yield). </li><li><strong>Serology titres</strong>: For IE, <strong>IgG ≥1:800</strong> is now <strong>Major</strong> (Duke-ISCVID 2023). Lower titres do <strong>not</strong> exclude Bartonella IE; rely on combined criteria. </li><li><strong>ANCA positivity</strong>: Bartonella IE can be <strong>PR3-ANCA positive</strong> with <strong>pauci-immune GN</strong> → can be mislabelled as AAV; treat the infection first. </li><li><strong>CSD therapy</strong>: Azithromycin helps nodes shrink faster but <strong>most cases resolve without antibiotics</strong>; use antibiotics for severe/atypical disease or immunocompromise. </li><li><strong>HIV BA/peliosis</strong>: treat for <strong>≥3 months</strong> and until lesions resolve; relapse if shorter; optimise ART. </li><li><strong>CSD (uncomplicated)</strong>: <strong>Azithromycin</strong> 500 mg day 1, then 250 mg daily × 4 days. <a href="https://www.cdc.gov/bartonella/hcp/bartonella-henselae/index.html?utm_source=chatgpt.com">CDC</a></li><li><strong>Ocular (neuroretinitis/POGS)</strong>: <strong>Doxy 100 mg bd + Rifampicin 300 mg bd × 4–6 wks</strong> (± steroids in severe neuroretinitis once antibiotics started). <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6742623/?utm_source=chatgpt.com">PMC</a></li><li><strong>BA/peliosis</strong>: <strong>Doxy 100 mg q12h</strong> <strong>or</strong> <strong>Erythro 500 mg q6h</strong> for <strong>≥3 mo</strong>; consider <strong>Rifampicin</strong> add-on for severe/CNS/ocular. <a href="https://www.ncbi.nlm.nih.gov/books/NBK586304/bin/oppguide.pdf">NCBI</a></li><li><strong>Trench fever (no IE)</strong>: <strong>Doxy 100 mg bd ≥4 wks</strong>; add <strong>Gentamicin</strong> 1 mg/kg q8h × 14 days if severe. <a href="https://emedicine.medscape.com/article/213169-treatment?utm_source=chatgpt.com">Medscape</a></li><li><strong>Endocarditis</strong>:<ul><li><strong>Doxy 100 mg q12h + Rifampicin 300 mg q12h × 6 wks</strong>, then <strong>continue Doxy</strong> ≥3 mo; <strong>or</strong></li><li><strong>Doxy 100 mg q12h + Gentamicin 1 mg/kg q8h × 14 days</strong>, then <strong>continue Doxy</strong> to complete ≥6 wks. (Adjust for renal function; prosthetic valves often need surgery.) <a href="https://www.ncbi.nlm.nih.gov/books/NBK586304/bin/oppguide.pdf">NCBI</a></li></ul></li><li><strong>Carrion’s disease</strong>:<ul><li><strong>Oroya fever</strong>: <strong>Ciprofloxacin</strong> (e.g., 500 mg bd) <strong>or</strong> <strong>Ceftriaxone</strong>; <strong>Chloramphenicol</strong> acceptable alternative.</li><li><strong>Verruga peruana</strong>: <strong>Azithro 7–14 days</strong> <strong>or</strong> <strong>Rifampicin 21–28 days</strong> (alt: fluoroquinolone).</li></ul></li></ul>
</div>